type:: [[paper]]
name:: High-Flow Nasal Cannula Oxygen in Patients Having Anesthesia for Advanced Esophagogastroduodenoscopy: HIFLOW-ENDO, a Randomized Clinical Trial
study-type:: [[RCT]] 
author:: Mazzeffi
year:: 2021
tags:: [[HFNC]], [[gastroenterologic procedure]], [[deep sedation]]

- ![mazzeffi-michael-a-high-flow-nasal-cannula-oxygen-in.pdf](../assets/mazzeffi-michael-a-high-flow-nasal-cannula-oxygen-in_1681825922867_0.pdf)
- advanced esophagogastroduodenoscopy #EGD
	- ((6445cb91-fe32-4119-b6b7-1508d87706d9))
- #supplement
	- document 1
		- ![aa_2020_03_30_mazzeffi_aa-d-19-01931r2_sdc1.pdf](../assets/aa_2020_03_30_mazzeffi_aa-d-19-01931r2_sdc1_1682295903820_0.pdf)
	- document 2
		- ![aa_2020_03_30_mazzeffi_aa-d-19-01931r2_sdc2.pdf](../assets/aa_2020_03_30_mazzeffi_aa-d-19-01931r2_sdc2_1682296085224_0.pdf)
-
# data collected
	- type:: hfnc-data
	  hfnc-flow:: 20
	  hfnc-fio2:: 
	  endpoints:: [[hypoxemia]], [[hypoxemia_92]] 
	  machine:: [[Vapotherm Precision Flow]]
	  procedure:: [[ERCP]], [[UGE]], [[endoscopic ultrasound]] 
	  sedation:: [[propofol]], [[midazolam]], [[fentanil]]
# conclusions
	- ((643ea1d7-5e63-463c-9c68-fe519fe0a81d))
	- HFNC oxygen significantly reduced the incidence of having one or more hypoxemia events from 33.1% to 21.2%
-